Skip to main content

News All News

Press Contact: Kirsten Mabry | (617) 495-4157

Tag: Blavatnik

March 31st, 2023

New approach to slowing aggressive leukemia

A team of Harvard and Sloan Kettering scientists has developed compounds that can target and degrade proteins associated with acute myeloid leukemia (AML) and nearly doubled the life expectancy of mice with cancer in laboratory tests.

Page 1 of 7